Abstract
Complicated urinary tract infection occurs in the setting of a functionally or structurally abnormal genitourinary tract. Many different abnormalities may lead to a designation of complicated urinary tract infection, and these abnormalities will have different influences on the frequency of infection and likelihood of relapse or reinfection. The microbiology of complicated urinary tract infection is characterised by a greater variety of organisms and increased likelihood of antimicrobial resistance compared with acute uncomplicated urinary tract infection.
Appropriate management requires a urine specimen for culture prior to institution of antimicrobial therapy, and ensuring that the underlying abnormality is fully characterised to determine whether it can be corrected. A wide variety of antimicrobial agents are effective for treatment, and are usually given for 7 to 14 days. If the underlying abnormality can be corrected, subsequent infections may be prevented. However, if the underlying abnormality cannot be corrected a high recurrence rate of infection, approaching 50% by 4 to 6 weeks, is expected. Further study of complicated urinary tract infection is necessary, including determination of when asymptomatic bacteriuria warrants treatment, and exploration of nonantimicrobial approaches to management.
Similar content being viewed by others
References
Nicolle LE. A practical guide to the management of complicated urinary tract infection. Drugs 1997; 53: 583–92
Ramsey JWA, Garnham AJ, Mulhall AB, et al. Biofilms, bacteria, and bladder catheters: a clinical study. Br J Urol 1984; 64: 395–8
Nicolle LE. Asymptomatic bacteriuria in the elderly. Infect Dis North Am 1997; 11: 647–67
Raz R, Gennesin Y, Wesser J, et al. Recurrent urinary tract infections in postmenopausal women. Clin Infect Dis 2000; 30: 152–6
Warren JW. Catheter-associated urinary tract infections. Infect Dis Clin North Am 1997; 11: 609–22
Waites KB, Canupp KC, DeVivo MJ. Epidemiology and risk factors for urinary tract infection following spinal cord injury. Arch Phys Med Rehab 1993; 74: 691–5
Larsen EH, Gusser TC, Madsen PO. Antimicrobial prophylaxis in urologic surgery. Urol Clin North Am 1986; 13: 591–604
Charton M, Vallencien G, Veillon B, et al. Use of antibiotics in conjunction with extracorporeal lithotripsy. Eur Urol 1990; 17: 134–8
Darouiche RD, Smith MS, Markowski J. Antibiotic prophylaxis for urodynamic resting in patients with spinal cord injury: a preliminary study. J Hosp Infect 1994; 28: 57–61
Damron DJ, Warren JW, Chippendale GR, et al. Do clinical microbiology laboratories report complete bacteriology in urine from patients with long term urinary catheters? J Clin Microbiol 1986; 24: 400–4
Waites KB, Canupp KC, DeVivo MJ. Efficacy and tolerance of norfloxacin in treatment of complicated urinary tract infection in outpatients with neurogenic bladder secondary to spinal cord injury. Urology 1991; 38: 589–96
Nicolle LE, Louie TJ, Dubois J, et al. Treatment of complicated urinary tract infections with lomefloxacin compared with trimethoprim/sulfamethoxazole. Antimicrob Agents Chemother 1994; 38: 1368–73
Cox CE, Holloway WJ, Geckler RW. Amulticenter comparative study of meropenem and imipenem/cilastatin in the treatment of complicated urinary tract infections in hospitalized patients. Clin Infect Dis 1995; 21: 86–92
Kauffman CA, Vazquez JA, Sobel JD, et al. Prospective, multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycose Study Group Clin. Infect Dis 2000; 30: 14–8
Nicolle LE. Urinary tract pathogens in complicated infection and in elderly individuals. J Infect Dis 2001; Mar 1; 183Suppl. 1: S5–8
Cardenas DD, Hooton TM. Urinary tract infection in persons with spinal cord injury. Arch Phys Med Rehab 1995; 76: 272–80
Rodgers K, Nocolle LE, McIntyre M, et al. Pyuria in institutionalized elderly subjects. Can J Infect Dis 1991; 2: 142–6
Rubin RH, Shapiro ED, Andriole VT, et al. Evaluation of new anti-infective drugs for treatment of urinary tract infection. Clin Infect Dis 1992; 15Suppl. 1: S216–27
Cafferky MT, Falkiner FR, Gillespie WA, et al. Antibiotic for the prevention of septicaemia in urology. J Antimicrob Chemother 1982; 9: 471–7
Patterson TF, Andriole VT. Detection, significance, and therapy of bacteriuria in pregnancy: update in the managed health care era. Infect Dis Clinics North Am 1997; 11: 593–603
Hansson S, Jodal U, Lincoln K, et al. Untreated asymptomatic bacteriuria in girls: II. Effect of phenoxymethylpenicllin and erythromycin given for intercurrent infections. BMJ 1989; 298: 856–9
Dow G, Thompson M, Harding G, et al. A double-blind randomized comparison of three versus fourteen days of ciprofloxacin in spinal cord injured patients with acute symptomatic urinary tract infection [abstract 584]. Clin Infect Dis 1997; 25: 463
Smith JW, Jones SR, Reed WP, et al. Recurrent urinary tract infections in men: characteristics and response to therapy. Ann Intern Med 1979; 91: 544–8
Gleckman R, Crowley M, Natsias GA. Recurrent urinary tract infections in men: an assessment of contemporary treatment. Am J Med Sci 1980; 279: 31–6
Gribble MJ, Puterman ML. Prophylaxis of urinary tract infection in persons with recent spinal cord injury: a prospective, randomized, double-blind, placebo controlled study of trimethoprim/sulfamethoxazole. Am J Med 1993; 95: 141–52
Sheehan GJ, Harding GKM, Haase DA, et al. Double-blind, randomized comparison of 24 weeks of norfloxacin followed by 12 weeks of placebo in the therapy of complicated urinary tract infection. Antimicrob Agents Chemother 1988; 32: 1292–3
Chinn RH, Maskell R, Mead JA, et al. Renal stones and urinary infection: a study of antibiotic treatment. BMJ 1976; 2: 1411–3
Fang G, Brennen C, Wagener M, et al. Use of ciprofloxacin versus use of aminoglycosides for therapy of complicated urinary tract infection: prospective, randomized, clinical and pharmacokinetic study. Antimicrob Agents Chemother 1991; 35: 1849–55
Hoepelman IM, Havinga WH, Benne RA, et al. Safety and efficacy of lomefloxacin versus norfloxacin in the treatment of complicated urinary tract infections. Eur J Clin Microbiol Infect Dis 1993; 12: 343–7
Nicolle LE, Mayhew WJ, Bryan L. Outcome following antimicrobial therapy for asymptomatic bacteriuria in elderly women resident in an institution. Age Aging 1988; 17: 187–92
Tambyah PA, Maki DG. Catheter-associated urinary tract infection is rarely symptomatic. Arch Intern Med 2000; 160: 678–82
Orr P, Nicolle LE, Duckworth H, et al. Febrile urinary infection in the institutionalized elderly. Am J Med 1996; 100: 71–7
Kunin CM, Douthitt S, Dancing J, et al. The association between the use of urinary catheters and morbidity and mortality among elderly patients in nursing homes. Am J Epidemiol 1992; 135: 291–301
Raz R, Schiller D, Nicolle LE. Chronic indwelling catheter replacement prior to antimicrobial therapy for symptomatic urinary infection. J Urol 2000; 164: 1254–8
Nicolle LE. The measurement and significance of antibiotic activity in the urine. In: Lorian J, editor Antibiotics in laboratory medicine. 4th ed. Baltimore (MD): Williams and Wilkins, 1996: P793–812
Zhanel G, Harding GKM, Nicolle LE. Asymptomatic bacteriuria in diabetics. Rev Infect Dis 1991; 13: 150–4
Nicolle LE. Asymptomatic bacteriuria in diabetic women. Diabetes Care 2000; 23: 722–3
Sobel JD, Kauffman CA, McKinsey D, et al. Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo. The National Institute for Allergy and Infectious Diseases (NIAID) Mycose Study Group. Clin Dis 2000; 30: 19–24
Leu HS, Huang CT. Clearance of funguria with short course antifungal regimens: a prospective, randomized controlled study. Clin Infect Dis 1995; 20: 1152–7
Jacobs LG, Skidmore EA, Freeman K, et al. Oral fluconazole compared with amphotericin B bladder irrigation for fungal urinary tract infection in the elderly. Clin Infect Dis 1996; 22: 30–5
Fan-Havard P, O’Donovan C, Smith SM, et al. Oral fluconazole versus amphotericin B bladder irrigation for treatment of candidal funguria. Clin Infect Dis 1995; 21: 960–5
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nicolle, L.E. A Practical Guide to Antimicrobial Management of Complicated Urinary Tract Infection. Drugs & Aging 18, 243–254 (2001). https://doi.org/10.2165/00002512-200118040-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-200118040-00002